This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Risk of recurrence of spontaneous pneumothorax

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

There is a significant rate of recurrence of both primary and secondary pneumothoraces

  • the recurrence rate for primary pneumothorax is more than 20% after the first episode and even greater after the second episode and tends to be more likely in women, tall men and smokers (1)

Management of recurrent spontaneous pneumothorax varies and the optimum procedure for preventing such recurrences remains controversial due to the lack of data comparing various recurrence prevention methods (2). Available treatment options include:

  • medical treatment
    • medical chemical plerurodesis
      • should only be used if a patient is either unwilling or unable to undergo surgery

  • surgical treatment
    • thoracoscopy with talc poudrage
    • video-assisted thoracoscopic surgery (VATS) with (partial) pleurectomy or talc poudrage
    • a thoracotomy with partial or complete pleurectomy
      • BTS suggests that open thoracotomy and pleurectomy remain the procedure with the lowest recurrence rate (approximately 1%) for difficult or recurrent pneumothoraces
    • BTS recommends that prevention of recurrent pneumothoraces should be undertaken surgically using either an open or VATS approach

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.